CRISPR gene-editing technology revolutionized disease research and drug discovery by facilitating convenient gene modification and high-throughput screening. Researchers now combine the power of CRISPR technology with the biological versatility of stem cells to develop better therapeutic models, uncover disease pathology, and identify viable pharmaceutical targets. This webinar will discuss recent disease and drug discoveries enabled through screening CRISPR-modified stem cells.
Topics to be covered
Speaker Information:
Graham MacLeod, PhD
Senior Research Associate
Laboratory of Stephane Angers, PhD
Department of Pharmaceutical Sciences
University of Toronto
David Brafman, PhD, MBA
Associate Professor, School of Biological and Health Systems Engineering
Director, Stem Cell Training and Research Program
Arizona State University
Drug Discovery News
1000 N West Street | Wilmington | Delaware | 19801 | US
Email: privacy@drugdiscoverynews.com
© 2021 Old River Publications LLC. All rights reserved
Drug Discovery News needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy